Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30702995 | 0.78 | RAB9A (0.48) | HPGDRAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL148972 | 0.78 | RAB9A (0.48) | HPGDRAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL16731967 | 0.76 | ALDH1A1 (0.32) | HPGDRAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL31408927 | 0.75 | ENPP2 (0.33) | — | |
| SCHEMBL12489287 | 0.74 | PDE5A (0.43) | HPGDNPC1 | |
| SCHEMBL31657742 | 0.74 | ENPP2 (0.39) | TP53TSHR | |
| Phenol SCHEMBL2225931 | 0.74 | VCP (0.43) | HPGDRAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL19023807 | 0.72 | BRD4 (0.55) | — | |
| SCHEMBL7913045 | 0.72 | NPC1 (0.44) | HPGDRAB9ASMN1; SMN2NPC1TSHR | |
| SCHEMBL45025 | 0.72 | IDO1 (0.43) | HPGDRAB9ASMN1; SMN2TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505614-A | Antioxidant vamp leather shoes and production process thereof | 赛纳（苏州）安防用品有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119505614-A | Antioxidant vamp leather shoes and production process thereof | 赛纳（苏州）安防用品有限公司 | 2025-02-25 | — | — | CN | disclosed |